4processed
Form 4 — Insider Transaction
RECURSION PHARMACEUTICALS, INC.(RXRX)
Filing Date
June 5, 2026
Accepted
June 5, 2026
Accession No.
0002020969-26-000004
CIK
0001601830
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Khan Najat | CEO and President | Other | 23.6K | $3.581 | — | 2.18M | Class A Common Stock | Jun 5, 2026 |